Literature DB >> 1483497

Correlations between theophylline concentrations in plasma, erythrocytes and cantharides-induced blister fluid and peak expiratory flow in asthma patients.

F Philip-Joet1, B Bruguerolle, M Reynaud, A Arnaud.   

Abstract

Theophylline levels in plasma, erythrocytes and cantharides-induced blister fluid (BF) have been correlated with peak expiratory flow (PEF) in asthmatic patients. Nine asthmatic men received an IV infusion of 240 mg theophylline at a constant rate for 30 min. The theophylline concentrations in erythrocytes and blister fluid were 37% and 78% of those in plasma. There was not a strong correlation between erythrocyte or blister fluid penetration and the clinical effect of theophylline.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483497     DOI: 10.1007/bf02285104

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

Review 1.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

2.  Erythrocyte binding of theophylline, determined by the EMIT system.

Authors:  B Bruguerolle
Journal:  Clin Chem       Date:  1986-05       Impact factor: 8.327

3.  Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea.

Authors:  H C Korting; M Schäfer-Korting; R Haag; E Mutschler
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1984-04

4.  Pharmacokinetics of brodimoprim in serum and skin blister fluid.

Authors:  T Kalager; A Digranes; A Salveson; T Bergan
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

5.  Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.

Authors:  M Schäfer-Korting; H C Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Does cantharides blister fluid provide access to the peripheral compartment?

Authors:  M Schäfer-Korting; H C Korting; S Hiemstra; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

7.  The pharmacokinetics and tissue penetration of ofloxacin.

Authors:  M R Lockley; R Wise; J Dent
Journal:  J Antimicrob Chemother       Date:  1984-12       Impact factor: 5.790

8.  Serum and subcutaneous chamber fluid dynamics of penicillins after single large parenteral doses.

Authors:  R R Tight; A C White
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Difference in blister fluid penetration after single and multiple doses of ceftriaxone.

Authors:  M LeBel; S Grégoire; M Caron; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac response.

Authors:  M Schäfer-Korting; G G Belz; J Brauer; R G Alken; E Mutschler
Journal:  Clin Pharmacol Ther       Date:  1987-12       Impact factor: 6.875

  10 in total
  3 in total

1.  Direct assessment of peripheral pharmacokinetics in humans: comparison between cantharides blister fluid sampling, in vivo microdialysis and saliva sampling.

Authors:  M Brunner; A Schmiedberger; R Schmid; D Jäger; E Piegler; H G Eichler; M Müller
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

2.  Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.

Authors:  Lucy Sasongko; Kenneth M Williams; Richard O Day; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

3.  Theophylline kinetics in peripheral tissues in vivo in humans.

Authors:  M Müller; B v Osten; R Schmid; E Piegler; I Gerngross; H Buchegger; H G Eichler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.